Literature DB >> 6835295

Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease.

R T Ellison, P F Kohler, J G Curd, F N Judson, L B Reller.   

Abstract

We evaluated the complement system in 20 patients presenting with a first episode of meningococcal meningitis, meningococcemia, or meningococcal pericarditis. Assays of total serum complement activity were performed prospectively in 12 patients and retrospectively in 8. Six of the twenty patients had a complement deficiency (CH50 greater than 2 S.D. below the normal mean). Three of these six had a deficiency of a terminal-pathway protein (C6 in two and C8 in one), and the other three had deficiencies of multiple complement proteins associated with underlying systemic lupus erythematosus or multiple myeloma. Patients with decreased amounts of complement were similar to normal patients in terms of sex, age, type of infection, and meningococcal serogroup, but 3 of the 6 patients with a complement deficiency were black, as compared with none of the 14 patients with normal function (P = 0.018). Complement deficiency is common in patients with a first episode of meningococcal disease and may be due to either a deficiency in a single terminal protein or a complement-depleting underlying illness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6835295     DOI: 10.1056/NEJM198304213081601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  36 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 2.  Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens.

Authors:  C G Vinuesa; C de Lucas; M C Cook
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

3.  Successful therapy of meningococcal sepsis in acute disseminated lupus erythematosus with plasmapheresis, immunosuppression, and antibiotics.

Authors:  G J Dobos; S Meske; E Keller; W Riegel; P Vaith; H H Peter; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1990-10-03

Review 4.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA.

Authors:  Z Zhu; T P Atkinson; K T Hovanky; S B Boppana; Y L Dai; P Densen; R C Go; J S Jablecki; J E Volanakis
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

6.  The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics.

Authors:  R S Heyderman; Y Ben-Shlomo; C A Brennan; M Somerset
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

7.  Meningococcal meningitis in a patient with urticarial vasculitis: is there a link?

Authors:  Hana Alachkar; Faieza Qasim; Yasmeen Ahmad; Matthew Helbert
Journal:  J Clin Pathol       Date:  2007-10       Impact factor: 3.411

Review 8.  Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis.

Authors:  Marc Tebruegge; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Meningococcal meningitis.

Authors:  S D Malnick; A Schattner
Journal:  BMJ       Date:  1990-06-30

10.  Pathogenesis, Therapy, and Prevention of Meningococcal Sepsis.

Authors:  David S. Stephens; Shanta M. Zimmer
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.